Everything below concerns reversed-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-05-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
=== Laboratory reactions === Sulfur dioxide is one of the few common acidic yet reducing gases. It turns moist litmus pink (being acidic), then white (due to its bleaching effect). It may be identified by bubbling it through a dichromate solution, turning the solution from orange to green (Cr3+ (aq)). It can also reduce ferric ions to ferrous. Sulfur dioxide can react with certain 1,3-dienes in a cheletropic reaction to form cyclic sulfones. This reaction is exploited on an industrial scale for the synthesis of sulfolane, which is an important solvent in the petrochemical industry.
Dial up Dial down Pendant up Pendant down Pendant left Pendant right Temperature (from 34 to 100 degrees Fahrenheit (1 to 38 °C)) Isochronism (the ability of the watch to keep time, regardless of the mainspring's level of tension) Positional adjustments are attained by careful poising (ensuring even weight distribution) of the balance-hairspring system as well as careful control of the shape and polish on the balance pivots. All of this achieves an equalization of the effect of gravity on the watch in various positions. Positional adjustments are achieved through careful adjustment of each of these factors, provided by repeated trials on a timing machine. Thus, adjusting a watch to position requires many hours of labor, increasing the cost of the watch. Medium grade watches were commonly adjusted to 3 positions (dial up, dial down, pendant up) while high grade watches were commonly adjusted to 5 positions (dial up, dial down, stem up, stem left, stem right) or even all 6 positions. Railroad watches were required, after 1908, to be adjusted to 5 positions. 3 positions were the general requirement before that time. Early watches used a solid steel balance. As temperature increased, the solid balance expanded in size, changing the moment of inertia and changing the timing of the watch. In addition, the hairspring would lengthen, decreasing its spring constant. This problem was initially solved through the use of the compensation balance. The compensation balance consisted of a ring of steel sandwiched to a ring of brass. These rings were then split in two places.
There is interest in using microbial therapeutics for cancer treatment. Some bacteria naturally grow well in low-oxygen environments, which are common inside tumors. These bacteria can move into tumors, remain there longer than many conventional treatments, and deliver therapeutic effects directly at the tumor site. Researchers are studying both natural and engineered bacteria that may slow tumor growth, stimulate immune responses against cancer, or work alongside existing cancer therapies.
Sources: en.wikipedia.org
== Quantum theory == In quantum mechanics, the energy of a quantum system is described by a self-adjoint (or Hermitian) operator called the Hamiltonian, which acts on the Hilbert space (or a space of wave functions) of the system. If the Hamiltonian is a time-independent operator, emergence probability of the measurement result does not change in time over the evolution of the system. Thus the expectation value of energy is also time independent. The local energy conservation in quantum field theory is ensured by the quantum Noether's theorem for the energy-momentum tensor operator. Thus energy is conserved by the normal unitary evolution of a quantum system. However, when the non-unitary Born rule is applied, the system's energy is measured with an energy that can be below or above the expectation value, if the system was not in an energy eigenstate. (For macroscopic systems, this effect is usually too small to measure.) The disposition of this energy gap is not well-understood; most physicists believe that the energy is transferred to or from the macroscopic environment in the course of the measurement process, while others believe that the observable energy is only conserved "on average". No experiment has been confirmed as definitive evidence of violations of the conservation of energy principle in quantum mechanics, but that does not rule out that some newer experiments, as proposed, may find evidence of violations of the conservation of energy principle in quantum mechanics.
== Other candies under the brand == Grapeheads (Discontinued) Cherryheads (Discontinued) Appleheads (Discontinued) Orangeheads (Discontinued) Chewy Lemonheads and Friends (including Lemonheads, Grapeheads, Cherryheads, Appleheads, and Orangeheads) (discontinued) Chewy Lemonheads Tropical (discontinued) Chewy Lemonheads Fruit Mix (discontinued) Chewy Lemonheads Flavor Fusers (discontinued) Chewy Lemonheads Pink Lemonade (discontinued) Lemonhead Ropes JuicyHeads (discontinued) BlueRaspberryheads (Discontinued) Raspberryheads (Discontinued) BlackRaspberryheads (Discontinued) LoveHeads (Discontinued) Lemonhead Freeze Dried
Cannabis tea, a cannabis-infused drink prepared by steeping various parts of the cannabis plant in hot or cold water Enviga, a carbonated green tea drink promoted with bogus health claims Jun, a fermented drink made from green tea and honey Kefir, a fermented dairy product Kvass, a traditional fermented drink made from bread List of unproven or disproven cancer treatments Mushroom tea, an infusion of mushrooms in water, made by using edible/medicinal mushrooms (such as lingzhi mushroom) or psychedelic mushrooms (such as Psilocybe cubensis) Tibicos, or "water kefir"
Sources: en.wikipedia.org
Vivien Jess. Learning Centre Manager, Education Training Service. For services to Defence and to the community in Northern Ireland. Dr Terry Martin John. Lately General Practitioner, The Firs Medical Centre, London Borough of Waltham Forest and lately Chair of International Committee, British Medical Association. For services to Medicine. Frances Barbara Johnson. Learning Support Assistant, Dame Tipping Church of England Primary School, Romford, London Borough of Havering. For services to Education. Louis Connor Johnson. For services to the community in Wolverhampton, West Midlands. Hilary Johnston. Founder, Cwtch Baby Bank. For services to Mothers and Babies in South East Wales. Monica Ann Johnston. Admission/Discharge Co-ordinator, Neurosciences, Belfast Health and Social Care. For services to Nursing and to the community in Northern Ireland. Anne Jones. For services to the community in Neston, Cheshire. Patricia Ellen Jones. For services to the community in Nailsworth, Gloucestershire. Sundeep Kaur. Director, United Sikhs. For services to the community in the West Midlands during Covid-19. Lisa Michelle Kay. For charitable services to Ukrainian Refugees and to the community in Solihull, West Midlands. Coral June Kelham. For services to the community in Barrow upon Soar, Leicestershire. Anne Marie Kelly. Lately Regional Office Manager, Northern Ireland Organ Donor Service. For services to Organ Donation and Transplantation in Northern Ireland. Richard Kennell. Chief Executive Officer, SOFEA. For services to Social Inclusion and to Alleviating Food Poverty.
=== Data breaches === In July 2018, Labcorp's servers were affected by a variant of the SamSam ransomware, with the goal of locking or disabling computers and servers to prevent access to data. The attack resulted in delays, but no data was believed to have been stolen. The malware was blocked on the network by midnight on July 14, 2018.
=== Psychiatric disorders === Beta blockers have been researched for treatment of a variety of psychiatric disorders besides anxiety disorders. These include depression, mania, acute stress disorder, post-traumatic stress disorder (PTSD), schizophrenia, aggression, and agitation. Beta blockers have also been used for the treatment of schizoid personality disorder. However, there is limited evidence supporting the efficacy of supplemental beta blocker use in addition to antipsychotic drugs for treating schizophrenia.
The core macrocycle, prerapamycin (figure 2), is then modified (figure 3) by an additional five enzymes, which lead to the final product, rapamycin. First, the core macrocycle is modified by RapI, SAM-dependent O-methyltransferase (MTase), which O-methylates at C39. Next, a carbonyl is installed at C9 by RapJ, a cytochrome P-450 monooxygenases (P-450). Then, RapM, another MTase, O-methylates at C16. Finally, RapN, another P-450, installs a hydroxyl at C27 immediately followed by O-methylation by Rap Q, a distinct MTase, at C27 to yield rapamycin. The biosynthetic genes responsible for rapamycin synthesis have been identified. As expected, three extremely large open reading frames (ORF's) designated as rapA, rapB, and rapC encode for three extremely large and complex multienzymes, RapA, RapB, and RapC, respectively. The gene rapL has been established to code for a NAD+-dependent lysine cycloamidase, which converts L-lysine to L-pipecolic acid (figure 4) for incorporation at the end of the polyketide. The gene rapP, which is embedded between the PKS genes and translationally coupled to rapC, encodes for an additional enzyme, an NPRS responsible for incorporating L-pipecolic acid, chain termination and cyclization of prerapamycin. In addition, genes rapI, rapJ, rapM, rapN, rapO, and rapQ have been identified as coding for tailoring enzymes that modify the macrocyclic core to give rapamycin (figure 3).
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.